Catheter-based renal sympathetic denervation: Chronic preclinical evidence for renal artery safety

Clinical Research in Cardiology

Volumn 100, Issue 12, 2011, Pages 1095-1101

  Rippy, Marian K ^a,b   Zarins, Denise ^c   Barman, Neil C ^c   Wu, Andrew ^c   Duncan, Keith L ^d   Zarins, Christopher K ^e  

^a Rippy Pathology Solutions   (United States)

^b Medtronic Ardian ^*  (United States)

^c Medtronic Ardian   (United States)

^d Peninsula Pathology Medical Group   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Hypertension; Nerves; Radiofrequency ablation; Renal artery

Indexed keywords

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD PRESSURE; CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE; DENERVATION; DOPPLER FLOWMETRY; FIBROSIS; HEALING; HISTOLOGY; HYPERPLASIA; HYPERTENSION; INFLAMMATION; KIDNEY ANGIOGRAPHY; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NERVE INJURY; NONHUMAN; PERINEURIUM; RADIOFREQUENCY ABLATION; RENAL ARTERY; SAFETY; SMOOTH MUSCLE; STROMA; SWINE; SYMPATHETIC NERVE;

EID: 84856020713     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0346-8     Document Type: Article

References (19)

1. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43(1):10-17. doi:10.1161/01.HYP.0000103630.72812.10 (Pubitemid 38031904)
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903-1913 (pii:S01406 73602119118) (Pubitemid 35472129)
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206-1252. doi: 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
4. World Health Organization (WHO) (2009) Global health risks: mortality and burden of disease attributable to selected major risks
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: Analysis of worldwide data. Lancet 365(9455):217-223. doi:10.1016/S0140-6736 (05)17741-1 (Pubitemid 40138015)
6. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 123(4):e18-e209. doi:10.1161/CIR. 0b013e3182009701
7. Erdine S (2010) Compliance with the treatment of hypertension: The potential of combination therapy. J Clin Hypertens (Greenwich) 12(1):40-46. doi:10.1111/j.1751-7176.2009.00200.x
8. Fergus IV (2009) Antihypertensive pharmacotherapy: Adverse effects of medications promote nonadherence. J Cardiometab Syndr 4(1):E1-E3. doi:10.1111/j.1559-4572.2008.00053.x
9. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 376(9756):1903-1909. doi: 10.1016/S0140-6736(10)62039-9
10. Di Bona GF (2002) Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11(2):197-200 (Pubitemid 34194740)
11. Di Bona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75-197 (Pubitemid 27069290)
12. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11(1):3-20 (Pubitemid 18086305)
13. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD (2004) Sympathetic augmentation in hypertension: Role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 43(2):169-175. doi:10.1161/01.HYP.0000103160. 35395.9E01 (Pubitemid 38174169)
14. DiBona GF, Esler M (2010) Translational medicine: The antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 298(2):R245-R253. doi:10.1152/ajpregu.00647. 2009
15. Esler M (2010) The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: The transition from mechanisms to medical management. J Appl Physiol 108(2):227-237. doi:10.1152/japplphysiol. 00832.2009
16. Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: Durability of blood pressure reduction out to 24 months. Hypertension 57(5):911-917. doi:10.1161/HYPERTENSIONAHA.110. 163014
17. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-ofprinciple cohort study. Lancet 373(9671):1275-1281. doi: 10.1016/S0140-6736(09)60566-3
18. Esler M, Schlaich M, Sobotka P, Whitbourn R, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham W, Krum H (2009) Catheter-based renal denervation reduces total body and renal noradrenaline spillover and blood pressure in resistant hypertension. J Hypertens 27(suppl 4):s167
19. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Bohm M (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: A pilot study. Circulation 123(18):1940-1946. doi: 10.1161/CIRCULATIONAHA.110.991869